about
Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattentionClinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic reviewStructural insights into the specific anti-HIV property of actinohivin: structure of its complex with the α(1–2)mannobiose moiety of gp120HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York CityOptimal Treatment Strategies in the Context of 'Treatment for Prevention' against HIV-1 in Resource-Poor SettingsEstablishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odysseyHIV treatment as prevention: optimising the impact of expanded HIV treatment programmesHIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.Immune interventions in HIV infection.Partner notification in the context of HIV: an interest-analysis.Evaluating respondent-driven sampling as an implementation tool for universal coverage of antiretroviral studies among men who have sex with men living with HIVNLM Workshop Marks 20 Years of Community Outreach and Capacity Building in HIV/AIDS.PEP and TasP Awareness among Italian MSM, PLWHA, and High-Risk Heterosexuals and Demographic, Behavioral, and Social CorrelatesHighlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure.Fundamental concerns of women living with HIV around the implementation of Option B+.Intergenerational sex as a risk factor for HIV among young men who have sex with men: a scoping reviewSexual and reproductive health and human rights of women living with HIV.30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject DrugsPositive affect promotes engagement in care after HIV diagnosis.Global Comparison of Drug Resistance Mutations After First-Line Antiretroviral Therapy Across Human Immunodeficiency Virus-1 Subtypes.NIH support of Centers for AIDS Research and Department of Health Collaborative Public Health Research: advancing CDC's Enhanced Comprehensive HIV Prevention Planning project.Re-focusing HIV prevention messages: a qualitative study in rural UgandaHigh HIV incidence in the postpartum period sustains vertical transmission in settings with generalized epidemics: a cohort study in Southern MozambiqueOpportunities for HIV combination prevention to reduce racial and ethnic health disparities.Implementation of HIV-related clinical research in the international setting.Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis.Assessing the cost effectiveness of pre-exposure prophylaxis for HIV prevention in the US.The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs?Maximizing the benefits of ART and PrEP in resource-limited settings.Protecting the health of our AIDS-free generation: beyond prevention of mother-to-child HIV transmission.Age-Specific Race and Ethnicity Disparities in HIV Infection and Awareness Among Men Who Have Sex With Men--20 US Cities, 2008-2014.Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes.HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART.'The world has changed': pharmaceutical citizenship and the reimagining of serodiscordant sexuality among couples with mixed HIV status in Australia.Sexual Debut and HIV-Related Sexual Risk-Taking by Birth Cohort Among Men Who Have Sex with Men in the United States.A Peer-Led HIV Medication Adherence Intervention Targeting Adults Linked to Medical Care but without a Suppressed Viral Load.Multi-scale immunoepidemiological modeling of within-host and between-host HIV dynamics: systematic review of mathematical modelsCrystallographic study of the interaction of the anti-HIV lectin actinohivin with the α(1-2)mannobiose moiety of gp120 HMTG.HIV treatment as prevention among men who have sex with men in the UK: is transmission controlled by universal access to HIV treatment and care?
P2860
Q27008531-64648B89-3096-4362-BFD9-018C47BA5C77Q27026742-386F4EDB-C8D0-48AF-B9F5-74CB588D98B7Q27675139-52771B92-AF3A-4634-AF77-5A23426556CDQ27687375-9571D461-D764-48CF-8FE0-13BA998D6E52Q28539412-50045D65-AEA5-49FD-B041-24AE2C3BAEFAQ28547109-3C4D3192-75C5-40CD-9A24-6BC33C7F1C50Q34280961-0B096B6F-F82B-4581-A0BB-86782F42E597Q34339517-D28F9198-F850-4306-89E1-D9B1E1A31440Q34339523-744160F8-6071-4CF8-8F75-E3C7A45DC849Q34351326-47621FFC-2041-4757-8C8E-EEA7AC1A8C31Q35568664-3005146E-CEE8-4C18-AF12-F071E4F26E08Q35782801-E8AF3CAB-2409-4D32-827F-F01B1919ABA5Q36004797-1788A8DA-94E4-49CD-97C8-85AA13119890Q36050331-9A733FD3-D391-4BA8-BA32-5970D37A60C0Q36320379-989E3A97-B935-4DE7-8F23-AD7FB671A9CAQ36353990-4053F26F-AD79-4D34-B533-10042AC83964Q36505248-2BF6169A-212A-4916-981A-C9361A067AC5Q36744865-EA59BD6D-EDE8-44B3-9D74-28A261B3A56EQ36959607-179EE60A-63B9-4247-B1D1-9C21905D9EF3Q36960549-8842255E-F0CD-4FB1-9348-EF9CBF4DC57CQ37091671-52357366-8499-4BB4-B527-9A570D83A003Q37384124-3BBD14E6-DE0D-4ADF-BD04-80DF525635E3Q37408947-1A770634-3704-4053-99B2-E8AAC3E48DC3Q37624539-181741EF-B633-4B07-9D2C-F3D1CB9174C1Q37627361-6AACF9DE-E09B-4ED3-8001-98EEA32D4046Q37638265-0E5C28D7-C76B-4B3A-9858-2275B5144731Q38105957-56796B16-2CD5-4CE0-95CF-1DE88240D098Q38165803-6F954589-D35E-4C0D-847A-77A5D2AA14AEQ38173892-0261DAE8-197D-4A71-865B-956DCC8FC3E5Q40392608-8E97CB5D-E3C8-42ED-9D49-FC76DFE16FFDQ40400569-4838D366-B627-4108-8AD9-8559F1D97FAFQ40408968-801E48A8-5DEF-4024-B998-A556EAAC5707Q40567577-E4141A62-AC73-4265-BC44-5160F1F1FCE8Q40695301-1BC775D8-58EE-4235-9B82-AF89E611796DQ41005289-47F43A9A-D49A-4E11-B18F-8CFF946BDB1FQ41629148-142DDE58-E12C-4F0A-9C07-6EBFE612509DQ41654417-F539C882-5A6B-45B0-9770-076DBEC91735Q41925810-84FB6DD2-4FC9-4F52-851A-761BBEF0C744Q41999950-C6524EDA-6C41-4657-8B9E-11BCC82AF1F8Q42253607-23A9F15A-D19C-4533-AB8A-E66F058F1A98
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Breakthrough of the year. HIV treatment as prevention
@ast
Breakthrough of the year. HIV treatment as prevention
@en
Breakthrough of the year. HIV treatment as prevention
@nl
type
label
Breakthrough of the year. HIV treatment as prevention
@ast
Breakthrough of the year. HIV treatment as prevention
@en
Breakthrough of the year. HIV treatment as prevention
@nl
prefLabel
Breakthrough of the year. HIV treatment as prevention
@ast
Breakthrough of the year. HIV treatment as prevention
@en
Breakthrough of the year. HIV treatment as prevention
@nl
P3181
P1433
P1476
Breakthrough of the year. HIV treatment as prevention
@en
P3181
P356
10.1126/SCIENCE.334.6063.1628
P407
P50
P577
2011-12-23T00:00:00Z